FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2151895026> ?p ?o ?g. }

• W2151895026 endingPage "364" @default.
• W2151895026 startingPage "358" @default.
• W2151895026 abstract "Objective To assess the utility of an extensive restaging examination performed after the completion of neoadjuvant chemotherapy (NAC) but before radical cystectomy (RC) in the management of patients with advanced bladder cancer. Methods We studied 62 patients who underwent NAC with the intent of proceeding to consolidative RC. A restaging examination, including endoscopic and bimanual examination, as well as cross-sectional imaging of the abdomen and pelvis, was performed after chemotherapy. The impact of restaging on clinical management was determined. In patients proceeding to RC, the degree of correlation between clinical stage (at diagnosis vs on restaging) and pathologic stage was determined. Results Restaging altered the treatment course in 6 patients (9.7%) in whom RC was not performed because of restaging findings. An additional 56 patients (90.3%) proceeded to RC. In these patients, compared with clinical stage at diagnosis, the postchemotherapy clinical stage correlated more strongly with pathologic stage (κ = 0.02 vs 0.17). On multivariate analysis, diagnostic clinical stage was not associated with pathologic stage (P = .85), whereas postchemotherapy clinical stage was strongly predictive of pathologic stage (P <.01). Conclusion An extensive restaging examination altered treatment strategy in a small, but clinically significant subset of patients treated with NAC for bladder cancer. Furthermore, restaging allowed for more accurate prediction of pathologic stage after RC, thereby improving assessment of patient prognosis. Consideration should be given to incorporating a restaging evaluation into the standard management paradigm for bladder cancer. To assess the utility of an extensive restaging examination performed after the completion of neoadjuvant chemotherapy (NAC) but before radical cystectomy (RC) in the management of patients with advanced bladder cancer. We studied 62 patients who underwent NAC with the intent of proceeding to consolidative RC. A restaging examination, including endoscopic and bimanual examination, as well as cross-sectional imaging of the abdomen and pelvis, was performed after chemotherapy. The impact of restaging on clinical management was determined. In patients proceeding to RC, the degree of correlation between clinical stage (at diagnosis vs on restaging) and pathologic stage was determined. Restaging altered the treatment course in 6 patients (9.7%) in whom RC was not performed because of restaging findings. An additional 56 patients (90.3%) proceeded to RC. In these patients, compared with clinical stage at diagnosis, the postchemotherapy clinical stage correlated more strongly with pathologic stage (κ = 0.02 vs 0.17). On multivariate analysis, diagnostic clinical stage was not associated with pathologic stage (P = .85), whereas postchemotherapy clinical stage was strongly predictive of pathologic stage (P <.01). An extensive restaging examination altered treatment strategy in a small, but clinically significant subset of patients treated with NAC for bladder cancer. Furthermore, restaging allowed for more accurate prediction of pathologic stage after RC, thereby improving assessment of patient prognosis. Consideration should be given to incorporating a restaging evaluation into the standard management paradigm for bladder cancer." @default.
• W2151895026 created "2016-06-24" @default.
• W2151895026 creator A5024005878 @default.
• W2151895026 creator A5031824644 @default.
• W2151895026 creator A5064618296 @default.
• W2151895026 creator A5071268553 @default.
• W2151895026 creator A5077350606 @default.
• W2151895026 creator A5077419364 @default.
• W2151895026 creator A5081659119 @default.
• W2151895026 date "2014-08-01" @default.
• W2151895026 modified "2023-10-12" @default.
• W2151895026 title "The Utility of an Extensive Postchemotherapy Staging Evaluation in Patients Receiving Neoadjuvant Chemotherapy for Bladder Cancer" @default.
• W2151895026 cites W1538189929 @default.
• W2151895026 cites W1560239325 @default.
• W2151895026 cites W1861912686 @default.
• W2151895026 cites W1975918912 @default.
• W2151895026 cites W2008523684 @default.
• W2151895026 cites W2019607817 @default.
• W2151895026 cites W2035062922 @default.
• W2151895026 cites W2048951696 @default.
• W2151895026 cites W2064975174 @default.
• W2151895026 cites W2073175347 @default.
• W2151895026 cites W2078191480 @default.
• W2151895026 cites W2103561213 @default.
• W2151895026 cites W2141230079 @default.
• W2151895026 cites W2619733974 @default.
• W2151895026 doi "https://doi.org/10.1016/j.urology.2014.03.040" @default.
• W2151895026 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4332781" @default.
• W2151895026 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25065987" @default.
• W2151895026 hasPublicationYear "2014" @default.
• W2151895026 type Work @default.
• W2151895026 sameAs 2151895026 @default.
• W2151895026 citedByCount "13" @default.
• W2151895026 countsByYear W21518950262015 @default.
• W2151895026 countsByYear W21518950262017 @default.
• W2151895026 countsByYear W21518950262018 @default.
• W2151895026 countsByYear W21518950262020 @default.
• W2151895026 countsByYear W21518950262021 @default.
• W2151895026 countsByYear W21518950262022 @default.
• W2151895026 countsByYear W21518950262023 @default.
• W2151895026 crossrefType "journal-article" @default.
• W2151895026 hasAuthorship W2151895026A5024005878 @default.
• W2151895026 hasAuthorship W2151895026A5031824644 @default.
• W2151895026 hasAuthorship W2151895026A5064618296 @default.
• W2151895026 hasAuthorship W2151895026A5071268553 @default.
• W2151895026 hasAuthorship W2151895026A5077350606 @default.
• W2151895026 hasAuthorship W2151895026A5077419364 @default.
• W2151895026 hasAuthorship W2151895026A5081659119 @default.
• W2151895026 hasBestOaLocation W21518950262 @default.
• W2151895026 hasConcept C121608353 @default.
• W2151895026 hasConcept C126322002 @default.
• W2151895026 hasConcept C126838900 @default.
• W2151895026 hasConcept C141071460 @default.
• W2151895026 hasConcept C146357865 @default.
• W2151895026 hasConcept C151730666 @default.
• W2151895026 hasConcept C2775910329 @default.
• W2151895026 hasConcept C2776694085 @default.
• W2151895026 hasConcept C2780352672 @default.
• W2151895026 hasConcept C527108885 @default.
• W2151895026 hasConcept C71924100 @default.
• W2151895026 hasConcept C86803240 @default.
• W2151895026 hasConceptScore W2151895026C121608353 @default.
• W2151895026 hasConceptScore W2151895026C126322002 @default.
• W2151895026 hasConceptScore W2151895026C126838900 @default.
• W2151895026 hasConceptScore W2151895026C141071460 @default.
• W2151895026 hasConceptScore W2151895026C146357865 @default.
• W2151895026 hasConceptScore W2151895026C151730666 @default.
• W2151895026 hasConceptScore W2151895026C2775910329 @default.
• W2151895026 hasConceptScore W2151895026C2776694085 @default.
• W2151895026 hasConceptScore W2151895026C2780352672 @default.
• W2151895026 hasConceptScore W2151895026C527108885 @default.
• W2151895026 hasConceptScore W2151895026C71924100 @default.
• W2151895026 hasConceptScore W2151895026C86803240 @default.
• W2151895026 hasIssue "2" @default.
• W2151895026 hasLocation W21518950261 @default.
• W2151895026 hasLocation W21518950262 @default.
• W2151895026 hasLocation W21518950263 @default.
• W2151895026 hasLocation W21518950264 @default.
• W2151895026 hasOpenAccess W2151895026 @default.
• W2151895026 hasPrimaryLocation W21518950261 @default.
• W2151895026 hasRelatedWork W123182686 @default.
• W2151895026 hasRelatedWork W1987461627 @default.
• W2151895026 hasRelatedWork W2022837219 @default.
• W2151895026 hasRelatedWork W2603025253 @default.
• W2151895026 hasRelatedWork W2999859356 @default.
• W2151895026 hasRelatedWork W3032049527 @default.
• W2151895026 hasRelatedWork W3129080622 @default.
• W2151895026 hasRelatedWork W4229366546 @default.
• W2151895026 hasRelatedWork W4315628570 @default.
• W2151895026 hasRelatedWork W2032434193 @default.
• W2151895026 hasVolume "84" @default.
• W2151895026 isParatext "false" @default.
• W2151895026 isRetracted "false" @default.
• W2151895026 magId "2151895026" @default.
• W2151895026 workType "article" @default.